Work

BRIGHT-4 trial: bivalirudin strikes back – Authors' reply

Year: 2023

Type: letter

Source: The Lancet

DOI: 10.1016/s0140-6736(23)00270-2

Authors: Yi Li, Zhenyang Liang, Gregg W Stone, Yaling Han

Institutions: General Hospital of Shenyang Military Region, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4362676509

Cites: 4

Cited by: 1

Related to: 10